S. L. Cockerham

发表

LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors

D. Schoepp, D. Bleakman, J. Monn, 1997, Neuropharmacology.

The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol class.

W. Jackson, M. Sofia, S. Silbaugh, 1997, Advances in experimental medicine and biology.

Inhaled A23187 produces a preferential sensitization to substance P.

A. Bendele, S. Silbaugh, P. Stengel, 1993, The American review of respiratory disease.

Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY293111: in vivo pulmonary studies

A. Bendele, W. Jackson, M. Sofia, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pulmonary actions of the neurokinin1-specific agonist [Sar9, Met(O2)11]-substance P

S. Silbaugh, P. Stengel, S. L. Cockerham, 1995, Neuropeptides.

Effect of dexamethasone on A23187-induced airway responses in the guinea pig.

A. Bendele, S. Silbaugh, P. Stengel, 1994, European journal of pharmacology.

Aerosolized LTB4 produces delayed onset increases in pulmonary gas trapping.

A. Bendele, W. Jackson, M. Sofia, 1996, Prostaglandins, leukotrienes, and essential fatty acids.

Effect of bronchoconstrictive aerosols on pulmonary gas trapping in the A/J mouse.

S. Silbaugh, P. Stengel, S. L. Cockerham, 1995, Respiration physiology.

Inhaled anandamide reduces leukotriene D4-induced airway obstruction in guinea pigs.

S. Silbaugh, P. Stengel, S. L. Cockerham, 2007, European journal of pharmacology.

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs.

W. Devane, S. Silbaugh, P. Stengel, 1998, European journal of pharmacology.

Quinoline-substituted dihydroindoles as cysLT1 (LTD4 receptor) antagonists

S. Silbaugh, J. S. Sawyer, P. Stengel, 1996 .

alkoxyphenol leukotriene B4 receptor antagonists

W. Jackson, M. Sofia, S. Silbaugh, 1992 .

-alkoxyphenol leukotriene B4 receptor antagonists: effect of a chroman carboxylic acid.

W. Jackson, M. Sofia, S. Silbaugh, 1992 .

Acid unit modifications of 1,2,4,5-substituted hydroxyacetophenones and the effect on in vitro and in vivo LTB4 receptor antagonism

W. Jackson, M. Sofia, S. Silbaugh, 1993 .

Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist.

S. Silbaugh, T. Goodson, D. K. Herron, 1992, European journal of pharmacology.

Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors.

G. Stephenson, R. Schmidt, S. Sweetana, 2012, Bioorganic & medicinal chemistry letters.

Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines

D. Lodge, J. Lowndes, A. Kingston, 1998, Neuropharmacology.

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure

S. Karathanasis, R. Schmidt, Youyan Zhang, 2011, Journal of Lipid Research.

Sulfuric acid induces airway hyperresponsiveness to substance P in the guinea pig

A. Bendele, S. Silbaugh, P. Stengel, 2005, Agents and Actions.

Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists.

M. Sofia, S. Silbaugh, J. S. Sawyer, 1993, Journal of Medicinal Chemistry.

Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.

W. Jackson, J. S. Sawyer, P. Floreancig, 1995, Journal of medicinal chemistry.

Synthetic and Structure-Activity Studies on Acid-Substituted 2- Arylphenols: Discovery of 2-(2-Propyl-3-(3-(2-ethyl-4-(4-fluorophenyl)- 5-hydroxyphenoxy)propoxy)phenoxy)benzoic Acid, a High-Affinity Leukotriene B4 Receptor Antagonist.

W. Jackson, M. Sofia, S. Silbaugh, 1996 .

Effects of inhaled or intravenous thiorphan on substance P-induced airway obstruction.

S. Silbaugh, P. Stengel, S. L. Cockerham, 1991, Agents and actions. Supplements.

Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors.

R. Schmidt, S. Sweetana, Youyan Zhang, 2012, Bioorganic & medicinal chemistry letters.